Immunomodulatory effects of low dose chemotherapy and perspectives of its combination with immunotherapy
出版年份 2012 全文链接
标题
Immunomodulatory effects of low dose chemotherapy and perspectives of its combination with immunotherapy
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF CANCER
Volume 132, Issue 11, Pages 2471-2478
出版商
Wiley
发表日期
2012-08-28
DOI
10.1002/ijc.27801
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- ChemoImmunoModulation: Immune Regulation by the Antineoplastic Chemotherapeutic Agents
- (2012) M. R. Shurin et al. CURRENT MEDICINAL CHEMISTRY
- Application of paclitaxel in low non-cytotoxic doses supports vaccination with melanoma antigens in normal mice
- (2012) Alexandra Sevko et al. Journal of Immunotoxicology
- Paclitaxel promotes differentiation of myeloid-derived suppressor cells into dendritic cellsin vitroin a TLR4-independent manner
- (2012) Tillmann Michels et al. Journal of Immunotoxicology
- Phase II trial of bevacizumab and dose/dense chemotherapy with cisplatin and metronomic daily oral etoposide in advanced non-small-cell-lung cancer patients
- (2011) Pierpaolo Correale et al. CANCER BIOLOGY & THERAPY
- Low-dose paclitaxel enhances the anti-tumor efficacy of GM-CSF surface-modified whole-tumor-cell vaccine in mouse model of prostate cancer
- (2011) Qiushan He et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Targeting myeloid regulatory cells in cancer by chemotherapeutic agents
- (2011) Hiam Naiditch et al. IMMUNOLOGIC RESEARCH
- Cetuximab ± chemotherapy enhances dendritic cell-mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen-specific cytotoxic T-cell response in vitro
- (2011) P. Correale et al. INTERNATIONAL JOURNAL OF CANCER
- Chemotherapeutic agents in low noncytotoxic concentrations increase immunogenicity of human colon cancer cells
- (2011) Ramon Kaneno et al. CELLULAR ONCOLOGY
- Combination strategies for enhancing the efficacy of immunotherapy in cancer patients
- (2010) Federica Moschella et al. Annals of the New York Academy of Sciences
- Dose/dense metronomic chemotherapy with fractioned cisplatin and oral daily etoposide enhances the anti-angiogenic effects of bevacizumab in advanced non-small-cell-lung cancer patients
- (2010) Pierpaolo Correale et al. CANCER BIOLOGY & THERAPY
- Low-Dose Cyclophosphamide Synergizes with Dendritic Cell-Based Immunotherapy in Antitumor Activity
- (2010) Joris D. Veltman et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice
- (2010) Rupal Ramakrishnan et al. JOURNAL OF CLINICAL INVESTIGATION
- Combined Inhibition of Notch Signaling and Bcl-2/Bcl-xL Results in Synergistic Antimyeloma Effect
- (2010) M. Li et al. MOLECULAR CANCER THERAPEUTICS
- Cyclophosphamide resets dendritic cell homeostasis and enhances antitumor immunity through effects that extend beyond regulatory T cell elimination
- (2009) Vedran Radojcic et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immunogenic chemotherapy with cyclophosphamide and doxorubicin against established murine carcinoma
- (2009) Miki Tongu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Low-Dose Metronomic Paclitaxel Chemotherapy Suppresses Breast Tumors and Metastases in Mice
- (2009) Hongchi Jiang et al. CANCER INVESTIGATION
- Dual Therapeutic Efficacy of Vinblastine as a Unique Chemotherapeutic Agent Capable of Inducing Dendritic Cell Maturation
- (2009) H. Tanaka et al. CANCER RESEARCH
- Bcl-2 Blocks Cisplatin-Induced Apoptosis and Predicts Poor Outcome Following Chemoradiation Treatment in Advanced Oropharyngeal Squamous Cell Carcinoma
- (2009) W. A. Michaud et al. CLINICAL CANCER RESEARCH
- A Novel Synergistic Combination of Cyclophosphamide and Gene Transfer of Interleukin-12 Eradicates Colorectal Carcinoma in Mice
- (2009) M. Malvicini et al. CLINICAL CANCER RESEARCH
- Chemotherapeutic Agents in Noncytotoxic Concentrations Increase Antigen Presentation by Dendritic Cells via an IL-12-Dependent Mechanism
- (2009) G. V. Shurin et al. JOURNAL OF IMMUNOLOGY
- Chemomodulation of human dendritic cell function by antineoplastic agents in low noncytotoxic concentrations
- (2009) Ramon Kaneno et al. Journal of Translational Medicine
- Epigenetic reversal of acquired resistance to 5-fluorouracil treatment
- (2009) R. Humeniuk et al. MOLECULAR CANCER THERAPEUTICS
- Platinum neurotoxicity pharmacogenetics
- (2009) S. R. McWhinney et al. MOLECULAR CANCER THERAPEUTICS
- Evolution of decitabine development
- (2008) Elias Jabbour et al. CANCER
- Immunogenic anti-cancer chemotherapy as an emerging concept
- (2008) Nicole M Haynes et al. CURRENT OPINION IN IMMUNOLOGY
- Immunogenic cancer cell death: a key-lock paradigm
- (2008) Antoine Tesniere et al. CURRENT OPINION IN IMMUNOLOGY
- Cancer Immunotherapy by Dendritic Cells
- (2008) Cornelis J.M. Melief IMMUNITY
- Lung infections after cancer chemotherapy
- (2008) Sandro Vento et al. LANCET ONCOLOGY
- Phase II Clinical Trial of Bevacizumab and Low-Dose Metronomic Oral Cyclophosphamide in Recurrent Ovarian Cancer: A Trial of the California, Chicago, and Princess Margaret Hospital Phase II Consortia
- (2007) Agustin A. Garcia et al. JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started